, /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of SelectQuote, Inc. (NYSE: SLQT). Investors who purchased shares of SelectQuote, Inc. (NYSE: SLQT) prior to September 2020 and continue to hold any of thoseNYSE: SLQT shares also have certain options and should contact he Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. On August 11, 2025, an investor inNYSE: SLQT shares filed a lawsuit against SelectQuote, Inc. ov ...

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information ...

Group 1 - A lawsuit is pending against Fortrea Holdings Inc. for alleged violations of securities laws, specifically concerning the company's financial disclosures and projections [1][2] - The lawsuit claims that Fortrea Holdings Inc. overstated revenue contributions from Pre-Spin Projects and inflated EBITDA targets for 2025, leading to misleading public statements about the company's financial health [2] - Investors who purchased shares of Fortrea Holdings Inc. prior to July 2023 are encouraged to contact the Shareholders Foundation for potential options [1][3] Group 2 - The Shareholders Foundation, Inc. provides services related to shareholder issues, including legal monitoring and information on securities class actions [3] - The organization is not a law firm and does not initiate legal actions, but serves as a public service to inform investors [3]

Core Viewpoint - A lawsuit has been filed against Lineage, Inc. for allegedly making false and misleading statements during its July 2024 IPO, particularly regarding its financial health and customer demand [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the registration statement for Lineage's IPO was misleading, failing to disclose a decline in customer demand due to increased cold-storage supply and destocking of excess inventory from the COVID-19 pandemic [2]. - It is alleged that Lineage's customers have shifted to maintaining leaner cold-storage inventories, impacting the company's revenue and occupancy rates negatively [2]. - The plaintiff argues that instead of the expected stable revenue growth and high occupancy rates, Lineage is experiencing stagnant or declining revenue, occupancy rates, and rent prices [2]. Group 2: Investor Information - Investors who purchased shares of Lineage, Inc. are encouraged to contact the Shareholders Foundation for information regarding their options related to the lawsuit [1][3].

Core Points - A lawsuit has been filed against Alto Neuroscience, Inc. (NYSE: ANRO) for alleged violations of securities laws related to its IPO and subsequent statements [3] - Investors who purchased over $100,000 in shares between February 2, 2024, and October 22, 2024, have a deadline of September 19, 2025, to take action [2] - The lawsuit claims that the effectiveness of ALTO-100 in treating Major Depressive Disorder (MDD) was overstated, leading to misleading public statements about the company's financial and business prospects [3] Company Information - Alto Neuroscience, Inc. is facing legal scrutiny due to allegations that its IPO documents contained false or misleading information regarding its product's effectiveness [3] - The Shareholders Foundation, Inc. is facilitating communication for affected investors and provides services related to shareholder issues and securities class actions [4]